Dr. Philip Greenberg , head of immunology and a member of the Clinical Research Division at Seattle’s Fred Hutchinson Cancer Research Center and a leader in cancer immunology, will describe how he and colleagues are genetically engineering T cells to seek out cancer cells, penetrate their defenses and kill them. In a presentation at the American Association for Cancer Research Annual Meeting 2016 in New Orleans, he also will provide a preview of next-generation strategies and upcoming clinical trials for a variety of cancers.
